Appili Therapeutics Inc. (TSE:APL – Get Rating) – Equities researchers at Zacks Small Cap issued their Q1 2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a research note issued on Thursday, July 14th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings per share of ($0.03) for the quarter. Zacks Small Cap also issued estimates for Appili Therapeutics' Q2 2023 earnings at ($0.02) EPS, Q3 2023 earnings at ($0.02) EPS and Q4 2023 earnings at ($0.02) EPS.
Appili Therapeutics Price Performance
See Also
- MarketBeat: Week in Review 7/11 – 7/15
- Is Coupang's Stock On The Verge Of A Turnaround?
- Should You Have These Two Banks In Your Portfolio?
- Verint Systems Stock is a Customer Engagement Play
- Why Shopify Stock Split...And is as Shoppable as Ever
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.